The Impact of the COVID-19 Pandemic on Italian Population-based Cancer Screening Activities and Test Coverage: Results from National Cross-sectional Repeated Surveys in 2020

Overview

Journal Elife

Specialty Biology

Date 2023 Feb 3

PMID 36734526

Authors

Paolo Giorgi Rossi

Giuliano Carrozzi

Patrizia Falini

Letizia Sampaolo

Giuseppe Gorini

Manuel Zorzi

Paola Armaroli

Carlo Senore

Priscilla Sassoli de Bianchi

Maria Masocco

Marco Zappa

Francesca Battisti

Paola Mantellini

Affiliations

Soon will be listed here.

Abstract

Background: In Italy, regions have the mandate to implement population-based screening programs for breast, cervical, and colorectal cancer. From March to May 2020, a severe lockdown was imposed due to the COVID-19 pandemic by the Italian Ministry of Health, with the suspension of screening programs. This paper describes the impact of the pandemic on Italian screening activities and test coverage in 2020 overall and by socioeconomic characteristics.

Methods: The regional number of subjects invited and of screening tests performed in 2020 were compared with those in 2019. Invitation and examination coverage were also calculated. PASSI surveillance system, through telephone interviews, collects information about screening test uptake by test provider (public screening and private opportunistic). Test coverage and test uptake in the last year were computed by educational attainment, perceived economic difficulties, and citizenship.

Results: A reduction of subjects invited and tests performed, with differences between periods and geographical macro areas, was observed in 2020 vs. 2019. The reduction in examination coverage was larger than that in invitation coverage for all screening programs. From the second half of 2020, the trend for test coverage showed a decrease in all the macro areas for all the screening programs. Compared with the pre-pandemic period, there was a greater difference according to the level of education in the odds of having had a test last year vs. never having been screened or not being up to date with screening tests.

Conclusions: The lockdown and the ongoing COVID-19 emergency caused an important delay in screening activities. This increased the preexisting individual and geographical inequalities in access. The opportunistic screening did not mitigate the impact of the pandemic.

Funding: This study was partially supported by Italian Ministry of Health - Ricerca Corrente Annual Program 2023 and by the Emilian Region DGR 839/22.

Citing Articles

Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period.

Acuti Martellucci C, Giacomini G, Flacco M, Manzoli L, Morettini M, Martellucci M Eur J Gen Pract. 2024; 30(1):2340672.

PMID: 38618885 PMC: 11020593. DOI: 10.1080/13814788.2024.2340672.

Equity in the recovery of elective and oncological surgery volumes after the COVID-19 lockdown: a multicentre cohort study in Italy.

Di Girolamo C, Onorati R, Landriscina T, Gnavi R, Cesaroni G, Calandrini E Int J Equity Health. 2024; 23(1):57.

PMID: 38491445 PMC: 10943780. DOI: 10.1186/s12939-024-02127-1.

Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries.

Vahabi M, Shahil-Feroz A, Lofters A, Wong J, Prakash V, Pimple S Healthcare (Basel). 2023; 11(23).

PMID: 38063647 PMC: 10706099. DOI: 10.3390/healthcare11233079.

Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics.

Amato O, Guarneri V, Girardi F Curr Opin Oncol. 2023; 35(6):612-619.

PMID: 37681462 PMC: 10566595. DOI: 10.1097/CCO.0000000000000991.

References

Toss A, Isca C, Venturelli M, Nasso C, Ficarra G, Bellelli V . Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era. ESMO Open. 2021; 6(2):100055. PMC: 7878116. DOI: 10.1016/j.esmoop.2021.100055. View

Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo O . Breast Cancer Diagnosis in Coronavirus-Era: Alert From Italy. Front Oncol. 2020; 10:938. PMC: 7258188. DOI: 10.3389/fonc.2020.00938. View

Mangone L, Mancuso P, Braghiroli M, Bisceglia I, Campari C, Caroli S . Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy. Cancers (Basel). 2022; 14(12). PMC: 9221346. DOI: 10.3390/cancers14123029. View

Rossi P, Petrelli A, Rossi A, Francovich L, Zappa M, Gargiulo L . [The inappropriateness in the use of female cancer screening tests in Italy: over- and under-utilization determinants]. Epidemiol Prev. 2019; 43(1):35-47. DOI: 10.19191/EP19.1.P35.019. View

Figueroa J, Gray E, Pashayan N, Deandrea S, Karch A, Vale D . The impact of the Covid-19 pandemic on breast cancer early detection and screening. Prev Med. 2021; 151:106585. PMC: 8241687. DOI: 10.1016/j.ypmed.2021.106585. View

Rossi P, Carrozzi G, Federici A, Mancuso P, Sampaolo L, Zappa M . Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes. J Med Screen. 2017; 25(1):17-23. DOI: 10.1177/0969141317704476. View

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21(8):1023-1034. PMC: 7417808. DOI: 10.1016/S1470-2045(20)30388-0. View

de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse E, Lew J . Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021; 6(4):304-314. PMC: 9767453. DOI: 10.1016/S2468-1253(21)00003-0. View

Ferrara G, De Vincentiis L, Ambrosini-Spaltro A, Barbareschi M, Bertolini V, Contato E . Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic. Am J Clin Pathol. 2020; 155(1):64-68. PMC: 7543252. DOI: 10.1093/ajcp/aqaa177. View

10.

Riccardo F, Guzzetta G, Urdiales A, Del Manso M, Andrianou X, Bella A . COVID-19 response: effectiveness of weekly rapid risk assessments, Italy. Bull World Health Organ. 2022; 100(2):161-167. PMC: 8795855. DOI: 10.2471/BLT.21.286317. View

11.

Peacock H, Tambuyzer T, Verdoodt F, Calay F, Poirel H, De Schutter H . Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 2021; 6(4):100197. PMC: 8411068. DOI: 10.1016/j.esmoop.2021.100197. View

12.

Duffy S, Seedat F, Kearins O, Press M, Walton J, Myles J . The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. Br J Cancer. 2022; 126(9):1355-1361. PMC: 8808468. DOI: 10.1038/s41416-022-01714-9. View

13.

Eijkelboom A, de Munck L, Lobbes M, van Gils C, Wesseling J, Westenend P . Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021; 151:106602. PMC: 9755636. DOI: 10.1016/j.ypmed.2021.106602. View

14.

Gathani T, Clayton G, MacInnes E, Horgan K . The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. Br J Cancer. 2020; 124(4):710-712. PMC: 7884714. DOI: 10.1038/s41416-020-01182-z. View

15.

Vanni G, Pellicciaro M, Materazzo M, Pedini D, Portarena I, Buonomo C . Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic. Anticancer Res. 2021; 41(5):2689-2696. DOI: 10.21873/anticanres.15050. View

16.

Blay J, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D . Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO Open. 2021; 6(3):100134. PMC: 8134718. DOI: 10.1016/j.esmoop.2021.100134. View

17.

Dinmohamed A, Cellamare M, Visser O, de Munck L, Elferink M, Westenend P . The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol. 2020; 13(1):147. PMC: 7609826. DOI: 10.1186/s13045-020-00984-1. View

18.

Bosch G, Posso M, Louro J, Roman M, Porta M, Castells X . Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study. Elife. 2022; 11. PMC: 9212994. DOI: 10.7554/eLife.77434. View

19.

Carrozzi G, Sampaolo L, Bolognesi L, Sardonini L, Bertozzi N, Rossi P . Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy. Epidemiol Prev. 2015; 39(3 Suppl 1):9-18. View

20.

Nyante S, Benefield T, Kuzmiak C, Earnhardt K, Pritchard M, Henderson L . Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures. Cancer. 2021; 127(12):2111-2121. PMC: 8013451. DOI: 10.1002/cncr.33460. View